Molecular profiling in lung biopsies of human pulmonary allografts to predict chronic lung allograft dysfunction

American Journal of Pathology

Volumn 185, Issue 12, 2015, Pages 3178-3188

  Jonigk, Danny ^a,b   Izykowski, Nicole ^a   Rische, Johanna ^a   Braubach, Peter ^a   Kühnel, Mark ^a   Warnecke, Gregor ^a,b   Lippmann, Torsten ^a   Kreipe, Hans ^a   Haverich, Axel ^a,b   Welte, Tobias ^a,b   Gottlieb, Jens ^a,b   Laenger, Florian ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MESSENGER RNA; SMAD1 PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL COMPOSITION; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS MACROPHAGE; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ALLOGRAFT; RESPIRATORY TRACT INFLAMMATION; TRANSBRONCHIAL BIOPSY; ADVERSE EFFECTS; BIOPSY; CELL COUNT; EARLY DIAGNOSIS; EVALUATION STUDY; GENE EXPRESSION; GENETICS; GRAFT REJECTION; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; BIOMARKERS; BIOPSY; BRONCHIOLITIS OBLITERANS; CELL COUNT; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; LUNG; LUNG TRANSPLANTATION; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, MESSENGER; YOUNG ADULT;

EID: 84947748106     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.08.016     Document Type: Article

References (74)

1. R.D. Yusen, L.B. Edwards, A.Y. Kucheryavaya, C. Benden, A.I. Dipchand, F. Dobbels, S.B. Goldfarb, B.J. Levvey, L.H. Lund, B. Meiser, and J. Stehlik International Society for Heart and Lung Transplantation: the registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation J Heart Lung Transplant 33 2014 1009 1024
2. A. Kapila, M.A. Baz, V.G. Valentine, S.M. Bhorade AIRSAC Investigators Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey J Heart Lung Transplant 34 2015 65 74
3. S.S. Weigt, A. DerHovanessian, W.D. Wallace, J.P. Lynch III, and J.A. Belperio Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation Semin Respir Crit Care Med 34 2013 336 351
4. A.F. Barker, A. Bergeron, W.N. Rom, and M.I. Hertz Obliterative bronchiolitis N Engl J Med 370 2014 1820 1828
5. J.P. Lynch III, S.S. Weigt, A. DerHovanessian, M.C. Fishbein, A. Gutierrez, and J.A. Belperio Obliterative (constrictive) bronchiolitis Semin Respir Crit Care Med 33 2012 509 532
6. M.A. Baz, D.T. Layish, J.A. Govert, D.N. Howell, C.M. Lawrence, R.D. Davis, and V.F. Tapson Diagnostic yield of bronchoscopies after isolated lung transplantation Chest 110 1996 84 88
7. D. Jonigk, M. Merk, K. Hussein, L. Maegel, K. Theophile, M. Muth, U. Lehmann, C.L. Bockmeyer, M. Mengel, J. Gottlieb, T. Welte, A. Haverich, H. Golpon, H. Kreipe, and F. Laenger Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs Am J Pathol 178 2011 599 608
8. M. Estenne, and M.I. Hertz Bronchiolitis obliterans after human lung transplantation Am J Respir Crit Care Med 166 2002 440 444
9. C. Ward, G.I. Snell, L. Zheng, B. Orsida, H. Whitford, T.J. Williams, and E.H. Walters Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection Am J Respir Crit Care Med 158 1998 84 91
10. R. Vos, B.M. Vanaudenaerde, S.E. Verleden, D. Ruttens, A. Vaneylen, D.E. Van Raemdonck, L.J. Dupont, and G.M. Verleden Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection Transplantation 94 2012 101 109
11. V. Subramanian, S. Ramachandran, B. Banan, A. Bharat, X. Wang, N. Benshoff, D. Kreisel, A.E. Gelman, and T. Mohanakumar Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation Am J Transplant 14 2014 2359 2366
12. D.J. Weber, and D.S. Wilkes The role of autoimmunity in obliterative bronchiolitis after lung transplantation Am J Physiol Lung Cell Mol Physiol 304 2013 L307 L311
13. D. Shitrit, D. Bendayan, S. Gidon, M. Saute, I. Bakal, and M.R. Kramer Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients J Heart Lung Transplant 24 2005 1440 1443
14. J.V. Gosselink, S. Hayashi, W.M. Elliott, L. Xing, B. Chan, L. Yang, C. Wright, D. Sin, P.D. Pare, J.A. Pierce, R.A. Pierce, A. Patterson, J. Cooper, and J.C. Hogg Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 2010 1329 1335
15. D. Jonigk, M. Al-Omari, L. Maegel, M. Muller, N. Izykowski, J. Hong, K. Hong, S.H. Kim, M. Dorsch, R. Mahadeva, F. Laenger, H. Kreipe, A. Braun, G. Shahaf, E.C. Lewis, T. Welte, C.A. Dinarello, and S. Janciauskiene Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase Proc Natl Acad Sci U S A 110 2013 15007 15012
16. B. Hinz, S.H. Phan, V.J. Thannickal, A. Galli, M.L. Bochaton-Piallat, and G. Gabbiani The myofibroblast: one function, multiple origins Am J Pathol 170 2007 1807 1816
17. I. Herrera, J. Cisneros, M. Maldonado, R. Ramirez, B. Ortiz-Quintero, E. Anso, N.S. Chandel, M. Selman, and A. Pardo Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption J Biol Chem 288 2013 25964 25975
18. M. Sato, D.M. Hwang, Z. Guan, J.C. Yeung, M. Anraku, D. Wagnetz, S. Hirayama, T.K. Waddell, M. Liu, and S. Keshavjee Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation Am J Pathol 179 2011 1287 1300
19. I.H. Heijink, D. Rozeveld, S. van der Heide, W. van der Bij, R. Bischoff, A.J. van Oosterhout, and M. van der Toorn Metalloproteinase profiling in lung transplant recipients with good outcome and bronchiolitis obliterans syndrome Transplantation 99 2015 1946 1952
20. E.L. Molloy, A. Adams, J.B. Moore, J.C. Masterson, L. Madrigal-Estebas, B.P. Mahon, and S. O'Dea BMP4 induces an epithelial-mesenchymal transition-like response in adult airway epithelial cells Growth Factors 26 2008 12 22
21. S. Pegorier, G.A. Campbell, A.B. Kay, and C.M. Lloyd Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF) Respir Res 11 2010 85
22. D. Jonigk, K. Theophile, K. Hussein, O. Bock, U. Lehmann, C.L. Bockmeyer, J. Gottlieb, S. Fischer, A. Simon, T. Welte, L. Maegel, H. Kreipe, and F. Laenger Obliterative airway remodelling in transplanted and non-transplanted lungs Virchows Arch 457 2010 369 380
23. M. Salama, P. Jaksch, O. Andrukhova, S. Taghavi, W. Klepetko, and S. Aharinejad Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients J Thorac Cardiovasc Surg 140 2010 1422 1427
24. G. Devouassoux, C. Pison, C. Drouet, I. Pin, C. Brambilla, and E. Brambilla Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection Transpl Immunol 8 2001 229 236
25. M. Reynaud-Gaubert, V. Marin, X. Thirion, C. Farnarier, P. Thomas, M. Badier, P. Bongrand, R. Giudicelli, and P. Fuentes Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration J Heart Lung Transplant 21 2002 721 730
26. F. Meloni, P. Vitulo, A. Cascina, T. Oggionni, A. Bulgheroni, E. Paschetto, C. Klersy, A.M. D'Armini, A. Fietta, A.M. Bianco, E. Arbustini, and M. Vigano Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome J Heart Lung Transplant 23 2004 1053 1060
27. S. Taghavi, K. Krenn, P. Jaksch, W. Klepetko, and S. Aharinejad Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans Am J Transplant 5 2005 1548 1552
28. R.H. Hübner, S. Meffert, U. Mundt, H. Bottcher, S. Freitag, N.E. El Mokhtari, T. Pufe, S. Hirt, U.R. Folsch, and B. Bewig Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation Eur Respir J 25 2005 494 501
29. R.C. Fields, A. Bharat, N. Steward, A. Aloush, B.F. Meyers, E.P. Trulock, W.C. Chapman, G.A. Patterson, and T. Mohanakumar Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation Transplantation 82 2006 1596 1601
30. B.S. Lu, A.D. Yu, X. Zhu, E.R. Garrity Jr., W.T. Vigneswaran, and S.M. Bhorade Sequential gene expression profiling in lung transplant recipients with chronic rejection Chest 130 2006 847 854
31. A. Bharat, K. Narayanan, T. Street, R.C. Fields, N. Steward, A. Aloush, B. Meyers, R. Schuessler, E.P. Trulock, G.A. Patterson, and T. Mohanakumar Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection Transplantation 83 2007 150 158
32. B.M. Vanaudenaerde, S.I. De Vleeschauwer, R. Vos, I. Meyts, D.M. Bullens, V. Reynders, W.A. Wuyts, D.E. Van Raemdonck, L.J. Dupont, and G.M. Verleden The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation Am J Transplant 8 2008 1911 1920
33. A.S. Golocheikine, D. Saini, S. Ramachandran, E.P. Trulock, A. Patterson, and T. Mohanakumar Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation Transpl Immunol 18 2008 260 263
34. C. Neurohr, P. Huppmann, B. Samweber, S. Leuschner, G. Zimmermann, H. Leuchte, R. Baumgartner, R. Hatz, L. Frey, P. Ueberfuhr, I. Bittmann, J. Behr Munich Lung Transplant Group Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients J Heart Lung Transplant 28 2009 468 474
35. S.M. Bhorade, H. Chen, L. Molinero, C. Liao, E.R. Garrity, W.T. Vigneswaran, R. Shilling, A. Sperling, A. Chong, and M.L. Alegre Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome Transplantation 90 2010 540 546
36. D.J. LaPar, M.D. Burdick, A. Emaminia, D.A. Harris, B.A. Strieter, L. Liu, M. Robbins, I.L. Kron, R.M. Strieter, and C.L. Lau Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker Ann Thorac Surg 92 2011 470 477 discussion 477
37. C. Reilly, T. Cervenka, M.I. Hertz, T. Becker, and C.H. Wendt Human neutrophil peptide in lung chronic allograft dysfunction Biomarkers 16 2011 663 669
38. T. Wolf, T. Oumeraci, J. Gottlieb, A. Pich, B. Brors, R. Eils, A. Haverich, B. Schlegelberger, T. Welte, M. Zapatka, and N. von Neuhoff Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients Transplantation 92 2011 477 485
39. D.J. Hall, M. Baz, M.J. Daniels, E.D. Staples, C.T. Klodell, L.L. Moldawer, and T.M. Beaver Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients Interact Cardiovasc Thorac Surg 15 2012 603 607
40. P.M. Fisichella, C.S. Davis, E. Lowery, L. Ramirez, R.L. Gamelli, and E.J. Kovacs Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation J Am Coll Surg 217 2013 90 100 discussion 100-101
41. R.J. Shah, S.L. Bellamy, J.C. Lee, E. Cantu, J.M. Diamond, N. Mangalmurti, S.M. Kawut, L.B. Ware, and J.D. Christie Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome Am J Transplant 13 2013 754 759
42. L.A. Borthwick, E.I. McIlroy, M.R. Gorowiec, M. Brodlie, G.E. Johnson, C. Ward, J.L. Lordan, P.A. Corris, J.A. Kirby, and A.J. Fisher Inflammation and epithelial to mesenchymal transition in lung transplant recipients: role in dysregulated epithelial wound repair Am J Transplant 10 2010 498 509
43. P. Jaksch, S. Taghavi, W. Klepetko, and M. Salama Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients J Thorac Cardiovasc Surg 148 2014 273 281
44. Z. Xu, D. Nayak, W. Yang, G. Baskaran, S. Ramachandran, N. Sarma, A. Aloush, E. Trulock, R. Hachem, G.A. Patterson, and T. Mohanakumar Dysregulated microRNA expression and chronic lung allograft rejection in recipients with antibodies to donor HLA Am J Transplant 15 2015 1933 1947
45. O. Brugiere, G. Thabut, I. Krawice-Radanne, R. Rizzo, G. Dauriat, C. Danel, C. Suberbielle, H. Mal, M. Stern, C. Schilte, M. Pretolani, E.D. Carosella, and N. Rouas-Freiss Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study Am J Transplant 15 2015 461 471
46. V. Brocker, F. Langer, T.G. Fellous, M. Mengel, M. Brittan, M. Bredt, S. Milde, T. Welte, M. Eder, A. Haverich, M.R. Alison, H. Kreipe, and U. Lehmann Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants Am J Respir Crit Care Med 173 2006 1276 1282
47. K.C. Meyer, G. Raghu, G.M. Verleden, P.A. Corris, P. Aurora, K.C. Wilson, J. Brozek, A.R. Glanville ISHLT/ATS/ERS BOS Task Force Committee, ISHLT/ATS/ERS BOS Task Force Committee An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome Eur Respir J 44 2014 1479 1503
48. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, and J. Wanger ATS/ERS Task Force: Standardisation of spirometry Eur Respir J 26 2005 319 338
49. D. Jonigk, F. Modde, C.L. Bockmeyer, J.U. Becker, and U. Lehmann Optimized RNA extraction from non-deparaffinized, laser-microdissected material Methods Mol Biol 755 2011 67 75
50. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, 2008.
51. C.M. Burton, M. Iversen, T. Scheike, J. Carlsen, and C.B. Andersen Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies Transplantation 85 2008 547 553
52. G.M. Verleden, L.J. Dupont, and D.E. Van Raemdonck Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 25 2005 221 224
53. S. Kesten, A. Maidenberg, T. Winton, and J. Maurer Treatment of presumed and proven acute rejection following six months of lung transplant survival Am J Respir Crit Care Med 152 1995 1321 1324
54. A.R. Glanville, C.L. Aboyoun, A. Havryk, M. Plit, S. Rainer, and M.A. Malouf Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation Am J Respir Crit Care Med 177 2008 1033 1040
55. M. Patella, M. Anile, P. Del Porto, D. Diso, Y. Pecoraro, I. Onorati, S. Mantovani, T. De Giacomo, F. Ascenzioni, E.A. Rendina, and F. Venuta Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation† Eur J Cardiothorac Surg 47 2015 1031 1036
56. J.A. Sullivan, A.B. Adams, and W.J. Burlingham The emerging role of TH17 cells in organ transplantation Transplantation 97 2014 483 489
57. J.E. Garcia, A.M. Lopez, M.R. de Cabo, F.M. Rodriguez, J.P. Losada, R.G. Sarmiento, A.J. Lopez, and J.L. Arellano Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level Mediators Inflamm 8 1999 253 259
58. J.E. Losa Garcia, F.M. Rodriguez, M.R. Martin de Cabo, M.J. Garcia Salgado, J.P. Losada, L.G. Villaron, A.J. Lopez, and J.L. Arellano Evaluation of inflammatory cytokine secretion by human alveolar macrophages Mediators Inflamm 8 1999 43 51
59. S. Alam, Z. Li, C. Atkinson, D. Jonigk, S. Janciauskiene, and R. Mahadeva Z alpha1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease Am J Respir Crit Care Med 189 2014 909 931
60. J.L. Tan, S.T. Chan, E.M. Wallace, and R. Lim Human amnion epithelial cells mediate lung repair by directly modulating macrophage recruitment and polarization Cell Transplant 23 2014 319 328
61. M. Ide, H. Ishii, H. Mukae, A. Iwata, N. Sakamoto, J. Kadota, and S. Kohno High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia Respir Med 102 2008 1625 1630
62. G.M. Di Guglielmo TSP-1 in lung fibrosis J Cell Commun Signal 4 2010 185 186
63. J.J. Grailer, M.D. Haggadone, J.V. Sarma, F.S. Zetoune, and P.A. Ward Induction of M2 regulatory macrophages through the beta2-adrenergic receptor with protection during endotoxemia and acute lung injury J Innate Immun 6 2014 607 618
64. D.T. Ploeger, N.A. Hosper, M. Schipper, J.A. Koerts, S. de Rond, and R.A. Bank Cell plasticity in wound healing: paracrine factors of M1/M2 polarized macrophages influence the phenotypical state of dermal fibroblasts Cell Commun Signal 11 2013 29
65. J.M. Munoz-Felix, M. Gonzalez-Nunez, and J.M. Lopez-Novoa ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe? Cytokine Growth Factor Rev 24 2013 523 537
66. T. Suzuki, P. Arumugam, T. Sakagami, N. Lachmann, C. Chalk, A. Sallese, S. Abe, C. Trapnell, B. Carey, T. Moritz, P. Malik, C. Lutzko, R.E. Wood, and B.C. Trapnell Pulmonary macrophage transplantation therapy Nature 514 2014 450 454
67. M. Brown, A.E. Postlethwaite, L.K. Myers, and K.A. Hasty Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts Clin Rheumatol 31 2012 973 981
68. K.A. Alexander, R. Flynn, K.E. Lineburg, R.D. Kuns, B.E. Teal, S.D. Olver, M. Lor, N.C. Raffelt, M. Koyama, L. Leveque, L. Le Texier, M. Melino, K.A. Markey, A. Varelias, C. Engwerda, J.S. Serody, B. Janela, F. Ginhoux, A.D. Clouston, B.R. Blazar, G.R. Hill, and K.P. MacDonald CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease J Clin Invest 124 2014 4266 4280
69. R.R. Hachem, V. Tiriveedhi, G.A. Patterson, A. Aloush, E.P. Trulock, and T. Mohanakumar Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation Am J Transplant 12 2012 2164 2171
70. J.T. Schwartze, S. Becker, E. Sakkas, L.A. Wujak, G. Niess, J. Usemann, F. Reichenberger, S. Herold, I. Vadasz, K. Mayer, W. Seeger, and R.E. Morty Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-beta signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts J Biol Chem 289 2014 3262 3275
71. K. Konishi, K.F. Gibson, K.O. Lindell, T.J. Richards, Y. Zhang, R. Dhir, M. Bisceglia, S. Gilbert, S.A. Yousem, J.W. Song, D.S. Kim, and N. Kaminski Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 180 2009 167 175
72. B. Shen, X. Liu, Y. Fan, and J. Qiu Macrophages regulate renal fibrosis through modulating TGFβ superfamily signaling Inflammation 37 2014 2076 2084
73. C. Rocher, R. Singla, P.K. Singal, S. Parthasarathy, and D.K. Singla Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages Can J Physiol Pharmacol 90 2012 947 951
74. S. Hoves, S.W. Krause, C. Schutz, D. Halbritter, J. Scholmerich, H. Herfarth, and M. Fleck Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells J Immunol 177 2006 2691 2698